Health Atlas
Menu
Evidence-led reference

Prevention & care

Long COVID and post-exertional malaise

7 sources · Latest source check 2026-10-07 UTC
On this page

Long COVID can involve symptoms that persist, change, or return after infection. CDC states that no laboratory test definitively diagnoses or rules it out.[1]

Testing and symptom patterns

A previous positive infection test is not required for diagnosis. CDC emphasizes history, clinical evaluation, and recognition of the impact on quality of life.[1]

Delayed worsening after exertion

CDC describes PEM as worsening typically 12–48 hours after exertion, sometimes lasting days or weeks. This is more than ordinary immediate tiredness; care should fit the symptoms and conditions present.[1]

A variable condition after infection

CDC describes Long COVID as a chronic condition after SARS-CoV-2 infection, present for at least three months. Symptoms may persist, relapse or change over time. It can occur after mild initial infection and in children as well as adults; reinfection can bring additional risk. Recovery trajectories differ, so one person’s experience does not establish the expected duration for everyone. No approved treatment specifically for Long COVID does not mean that symptom-focused care is unavailable.[2]

Fatigue and brain fog are only part of the picture

Reported patterns include fatigue, concentration problems, breathlessness, palpitations, dizziness on standing, sleep changes, altered smell or taste and gastrointestinal symptoms. These may overlap with other conditions and can substantially affect daily life. After intensive-care illness, weakness and cognitive or trauma-related problems can also contribute; they are not necessarily attributable to the virus alone. The clinical question is which problems are present and what else could explain or worsen them.[3]

Normal routine tests do not settle the whole question

CDC advises against assessing wellbeing solely from objective findings or dismissing symptoms. Testing can identify complications or alternative explanations, although no single test confirms or excludes Long COVID. Post-exertional malaise requires attention to delayed worsening and individual limits; a fixed exercise progression cannot be assumed appropriate for everyone.[1]

A definition needs its organization, date and timing rule

A definition needs its organization, date and timing rule
DefinitionSelected timing and scope
WHO 2021 adult case definitionUsually three months from COVID-19 onset; symptoms last at least two months and have no alternative explanation. Probable or confirmed infection is included.[5]
2024 NASEM definitionAn infection-associated condition present for at least three months; patterns can be continuous, relapsing/remitting or progressive.[6]

A classification duration is not a waiting period for care

The 2024 National Academies report distinguishes its minimum duration from when symptoms deserve recognition and assessment. It allows delayed onset and variable courses; research eligibility may narrow the broad definition for a particular study. Neither this terminology comparison nor a time threshold proves that every symptom after infection has one cause.[6]

Missing an infection test and establishing a clinical explanation are separate issues

The National Academies report does not require laboratory proof of the original infection. It also acknowledges false inclusion and the need to consider alternative explanations. A positive historical test alone is not a complete explanation of current symptoms, while a missing old test should not automatically exclude the condition.[6]

Overlapping patterns do not mean everyone has an identical syndrome

WHO’s 2025 fact sheet describes clusters involving dizziness or palpitations on standing, exertion intolerance and post-exertional malaise, alongside other symptoms and conditions. These patterns may overlap with POTS or ME/CFS. Naming an overlap does not diagnose every person with either condition or establish one mechanism and treatment for all.[7]

Evidence & uncertainty

Definitions differ. Symptoms and course vary; timing alone cannot settle every clinical question.[5][6]

Selected-source overview · Independent review pending

Published questions

Can a normal laboratory test rule out Long COVID?

Selected-source overview · Independent review pending. Read the evidence context.

No single laboratory test definitively rules it out.[1]

Evidence behind this answer

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Can Long COVID symptoms return after improving?

Selected-source overview · Independent review pending. Read the evidence context.

Yes. CDC describes symptoms that evolve, resolve, and reemerge.[1]

Evidence behind this answer

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

What is post-exertional malaise in Long COVID?

Selected-source overview · Independent review pending. Read the evidence context.

Delayed symptom worsening after even minor physical or mental effort.[1]

Evidence behind this answer

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Can Long COVID follow an initially mild infection?

Selected-source overview · Independent review pending. Read the evidence context.

Yes. CDC describes Long COVID after different initial illness severities and in children and adults.[2]

Evidence behind this answer
  • Long COVID Basics

    agency explanation · 2026-05-06
    Selected page text; cited sections · Definition, variable course and affected populations

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Does everyone with Long COVID have the same symptoms?

Selected-source overview · Independent review pending. Read the evidence context.

No. Multisystem symptoms and functional effects vary and overlap with other conditions, requiring attention to the individual pattern.[3]

Evidence behind this answer
  • Long COVID Signs and Symptoms

    agency explanation · Date not stated
    Selected page text; cited sections · Multisystem symptoms, functional impact and post-intensive care syndrome

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Do normal routine tests prove that persistent symptoms are unimportant?

Selected-source overview · Independent review pending. Read the evidence context.

No. CDC cautions against judging wellbeing only from objective tests; evaluation can still investigate complications and alternative explanations.[1]

Evidence behind this answer

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Does STOP-PASC prove that every antiviral approach to Long COVID fails?

Selected-source overview · Independent review pending. Read the evidence context.

No. It did not show benefit for one studied regimen and pooled symptom outcome; other populations and approaches remain separate questions.[4]

Evidence behind this answer

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Can intensive-care recovery contribute to symptoms after COVID?

Selected-source overview · Independent review pending. Read the evidence context.

Yes. Post-intensive care syndrome can involve weakness, cognitive problems and trauma-related symptoms, complicating attribution to infection alone.[3]

Evidence behind this answer
  • Long COVID Signs and Symptoms

    agency explanation · Date not stated
    Selected page text; cited sections · Multisystem symptoms, functional impact and post-intensive care syndrome

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

What makes long COVID different from taking a couple of weeks to recover from an infection?

Selected-source overview · Independent review pending. Read the evidence context.

CDC's current definition describes a condition after SARS-CoV-2 infection present for at least three months. Symptoms can persist, fluctuate or reappear and affect different body systems. A few weeks of recovery alone does not establish that condition. There is no definitive laboratory test; clinical assessment considers history, symptoms and other explanations. Definitions and research questions also need their stated timeframe.[2]

Evidence behind this answer
  • Long COVID Basics

    agency explanation · 2026-05-06
    Selected page text; cited sections · Definition, variable course and affected populations

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Do WHO and NASEM use exactly the same Long COVID timing definition?

Selected-source overview · Independent review pending. Read the evidence context.

No. WHO 2021 describes usual occurrence three months from COVID-19 onset and symptoms lasting at least two months; NASEM 2024 requires at least three months’ duration.[5][6]

Evidence behind this answer

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Does a three-month definition mean earlier symptoms must be ignored?

Selected-source overview · Independent review pending. Read the evidence context.

No. The NASEM report explicitly says concerning symptoms should be recognized and assessed before that classification duration is reached.[6]

Evidence behind this answer
  • Defining Long COVID — A Long COVID Definition

    original consensus report chapter · 2024
    Selected relevant original page passages inspected · Core timing; care before three months; missing infection proof; false inclusion and operationalization

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Does the NASEM definition require a positive test from the original infection?

Selected-source overview · Independent review pending. Read the evidence context.

No. Laboratory confirmation is not required; clinical assessment must still weigh the history and alternative explanations.[6]

Evidence behind this answer
  • Defining Long COVID — A Long COVID Definition

    original consensus report chapter · 2024
    Selected relevant original page passages inspected · Core timing; care before three months; missing infection proof; false inclusion and operationalization

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Does a Long COVID label mean everyone also has POTS or ME/CFS?

Selected-source overview · Independent review pending. Read the evidence context.

No. WHO describes overlapping symptom patterns, not an identical set of diagnoses in every person. Each clinical question needs its own assessment.[7]

Evidence behind this answer
  • Post COVID-19 condition (long COVID)

    agency explanation · 2025
    Selected relevant original page passages inspected · Symptoms: orthostatic/exertional clusters and overlap with POTS/ME-CFS

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

What one antiviral trial found

STOP-PASC randomized 155 adults with longstanding post-COVID symptoms to a 15-day nirmatrelvir-ritonavir course or placebo-ritonavir. The study did not find a statistically significant benefit for its pooled symptom outcome at ten weeks. This is a bounded result for that regimen, population and follow-up, rather than proof that all antivirals, all mechanisms or all subgroups are ineffective. It also does not evaluate treatment of acute COVID in an eligible patient.[4]

Questions still to cover

Further work: completed treatment trials by symptom subgroup and outcome; post-exertional malaise-specific rehabilitation comparisons; pediatric care, alternative diagnoses and local care pathways.

References

  1. Long COVID Clinical Guidance

    Agency clinical guidance

    CDC · Content/publication date: 2026
    Accessed: 2026-10-06 UTC · Selected page sections
    Cited sections: Diagnosis; presentation; management; PEM

  2. Long COVID Basics

    Agency explanation

    CDC · Content/publication date: 2026-05-06
    Accessed: 2026-10-06 UTC · Selected page text; cited sections
    Cited sections: Definition, variable course and affected populations

  3. Long COVID Signs and Symptoms

    Agency explanation

    CDC · Content/publication date: not stated
    Accessed: 2026-10-06 UTC · Selected page text; cited sections
    Cited sections: Multisystem symptoms, functional impact and post-intensive care syndrome

  4. Nirmatrelvir-Ritonavir and Symptoms in Adults With Postacute Sequelae of SARS-CoV-2 Infection: The STOP-PASC Randomized Clinical Trial

    Randomized trial

    Geng LN et al. · Content/publication date: 2024
    Accessed: 2026-10-06 UTC · Indexed primary-study abstract returned by search
    Cited sections: Abstract: methods and findings

    Abstract inspected. A listed erratum concerns Figure 2; figure data and full adverse-event tables were not extracted.

  5. A clinical case definition of post COVID-19 condition by a Delphi consensus

    Original consensus definition

    WHO · Content/publication date: 2021
    Accessed: 2026-10-07 UTC · Original publication overview inspected; full consensus methods not appraised
    Cited sections: Overview: probable/confirmed infection, timing, duration, alternatives and course

    Selected adult definition; separate pediatric definition exists.

  6. Defining Long COVID — A Long COVID Definition

    Original consensus report chapter

    National Academies of Sciences, Engineering, and Medicine · Content/publication date: 2024
    Accessed: 2026-10-07 UTC · Selected relevant original page passages inspected
    Cited sections: Core timing; care before three months; missing infection proof; false inclusion and operationalization

    Selected original chapter passages, not an independent appraisal of the full report or every underlying study.

  7. Post COVID-19 condition (long COVID)

    Agency explanation

    WHO · Content/publication date: 2025
    Accessed: 2026-10-07 UTC · Selected relevant original page passages inspected
    Cited sections: Symptoms: orthostatic/exertional clusters and overlap with POTS/ME-CFS

    Selected symptom-pattern explanation; no causal effect sizes or treatment regimen extracted.

Scope & review

Population
People with symptoms after COVID-19
Exposure or intervention
Persistent symptoms, definition timing, infection confirmation, overlapping patterns and symptom support
Comparison
WHO 2021 adult and NASEM 2024 definitions; no full treatment-trial review
Outcomes
Symptoms, function and quality of life; no diagnostic accuracy estimate
Timeframe
Definition-specific duration rules and variable course; not a required waiting period for care
Jurisdiction
US CDC guidance, WHO adult definition and 2025 overview, and US National Academies terminology

Selected-source educational explainer. Cited page sections or indexed abstracts were inspected as specified for each source. This is not a systematic search, a formal evidence grade, or an independent clinical expert review; topic and applicability judgments are editorial. Edition 3.11 adds selected condition, hygiene and exercise definitions and examples, with scoped introductory links; older reference access dates remain explicit.

Sources checked on their individual access dates. Selected sources were checked; ongoing surveillance and qualified review have separate statuses on the coverage page.

Revision history
  • 2026-10-06 UTC: Bounded foundation added with source locators, scope, and unresolved expansion areas.
  • 2026-10-06 UTC: Expanded definitions, categories, evidence boundaries and locally sourced questions; selected sources checked with access limits recorded. Independent expert review remains incomplete.
  • 2026-10-07 UTC: Edition 3.11: added selected condition, hygiene and exercise definitions, comparisons, examples and sourced questions. Earlier anchors and access dates retained; qualified review remains pending.
  • 2026-10-07 UTC: Edition 3.11 evidence-context update: state differing definitions and variable course up front; existing symptom-support sections retained.

What this article still leaves open

  • completed treatment trials by symptom subgroup and outcome
  • post-exertional malaise-specific rehabilitation comparisons
  • pediatric care, alternative diagnoses and local care pathways
  • Definition validation across settings, updated mechanisms and interventions, population differences and full rehabilitation/PEM evidence.
Suggest a correction

Submit a content correction to the editorial queue, or download a local note. Leave out personal medical details. Submitted text is stored privately with a browser receipt session and is visible to this browser and the editor. Clearing cookies removes access to your submission history. This is not an account or a medical service.

Explore the topic map

Browse the health domains connected to this article. The map also identifies topics whose articles remain unwritten.